Drawing for AVTRA

USPTO serial 76333965

AVTRA

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
ROTH, JASON I
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with AVTRA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Tiffany Trunko

TIFFANY TRUNKO C/O PFIZER INC150 E 42ND STNEW YORK, NY 10017-5612UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation and inflammatory diseases, respiratory and infectious diseases, and immunological, bacterial, viral and fungal disorders; pharmaceutical preparations, namely, cholesterol preparations, tissue and skin repair preparations, dermatological preparations, gynecological preparations and smoking cessation preparationsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 15, 2002ABN1ABANDONMENT - EXPRESS MAILED—
Apr 23, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 15, 2002CNSLLETTER OF SUSPENSION MAILED—
Jan 9, 2002DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance